Published: October 30, 2015

Editorial

October 30, 2015
1-1
A A Farooqi, M Ismail

The role of microRNAs in the resistance to colorectal cancer treatments

October 30, 2015
17-23
R Amirkhah, A Farazmand, M Irfan-Maqsood, O Wolkenhauer, O Wolkenhauer, U Schmitz

Natural products are the future of anticancer therapy: Preclinical and clinical advancements of Viscum album phytometabolites

October 30, 2015
62-68
R Attar, S Tabassum, S Fayyaz, M S Ahmad, D R Nogueira, I Yaylim, O Timirci-Kahraman, O Kucukhuseyin, C Cacina, A A Farooqi, M Ismail

ASPP and iASPP: Implication in cancer development and progression

October 30, 2015
2-8
Y Li, A Ahmad, F H Sarkar

The Notch signaling pathway in esophageal adenocarcinoma

October 30, 2015
24-32
Z Wang, J Chen, A J Capobianco

Targeting post-translational modifications of histones for cancer therapy

October 30, 2015
69-84
Y-C Hsu, Y-H Hsieh, C-C Liao, L-W Chong, C-Y Lee, Y-L Yu, R-H Chou

Association of NOTCH with different microRNAs in head and neck cancer

October 30, 2015
9-16
N Masood, M Z Qureshi, A Yasmin

PARP inhibition: A promising therapeutic target in ovarian cancer

October 30, 2015
44-61
A Musella, C Marchetti, M L Gasparri, L Salerno, A Casorelli, L Domenici, L Imperiale, I Ruscito, T Abdul Halim, I Palaia, V Di Donato, F Pecorini, M Monti, L Muzii, P B Panici

TRAIL and targeting cancer cells: between promises and obstacles

October 30, 2015
33-38
Y Limami, A Pinon, A Riaz, A Simon

Cancer stem cells in head and neck cancer: A Mini Review

October 30, 2015
39-43
A L Silva Galbiatti-Dias, í‰ C Pavarino, R S Kawasaki-Oyama, J V Maniglia, E J V Maniglia, E M Goloni Bertollo